FDA turns to Fre­se­nius im­ports from EU to help with com­mon can­cer drug short­age

The FDA ac­knowl­edged to­day that it’s been al­low­ing tem­po­rary im­ports of the com­mon­ly used can­cer drug cis­platin from Fre­se­nius Kabi to help shore up the con­tin­u­ing short­age of the drug na­tion­wide.

The prod­uct that’s be­ing al­lowed in­to the coun­try is mar­ket­ed in Eu­rope and man­u­fac­tured in In­dia, but still not FDA-ap­proved, ac­cord­ing to a let­ter FDA sent Aug. 30 and shared on so­cial me­dia Thurs­day. FDA’s drug short­age site said there would be “lim­it­ed avail­abil­i­ty” of the prod­uct be­gin­ning Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER